Perfuzia Medical

Medtech · Private

ActiveFlow, a topical wound healing device combining active perfusion/oxygenation stimulation with advanced wound bed treatment

perfuzia.com →
Grants
$149K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
$150K
1 award · Defense
#488 of 4531 in medtech
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · Igf::ot::igf STTR Phase 1 - A14A-016-0166$149,737
Federal grantDepartment of Defense · Phase I · Development of novel wound dressing technology combining advanced hydrogel and perfusion enhancement technologies.$149,373
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
485CELL PRESERVATION SERVICES INC$150K—
486Transient Electronics Inc.$150K—
487SOFTSONICS LLC$150K—
488Perfuzia Medical$150K—
489Cytoimage Inc.$150K$225K
490CANTON BIOTECHNOLOGIES, INC.$149K—
491Awarables, Inc.$149K$500K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Actuator For Delivery Of Vibratory Stimulation To An Area Of The Body And Method Of Applicationapplication
  • Devices And Methods For Manipulating Circulation In The Circulatory System Of A Patientapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.